Malignant melanoma: Conceptual and therapeutic innovations based on translational research;Comment je traite... Le mélanome cutané: Innovations conceptuelles et thérapeutiques, fruit de la recherche translationnelle

Revue Medicale de Liege

Volumn 63, Issue 10, 2008, Pages 579-584

  Pierard G E ^a   Quatresooz, P ^a   Rorive, A ^a   Pierard Franchimont C ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Diagnostic; Epidemiology; Mage A3; Melanoma; Sentinel lymph node

Indexed keywords

ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT; ALPHA INTERFERON; IMMUNOLOGIC FACTOR; MAGEA3 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER INCIDENCE; CONCEPTUAL FRAMEWORK; DIAGNOSTIC PROCEDURE; GANGLION; HUMAN; MEDICAL RESEARCH; MELANOMA; VACCINATION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; TREATMENT OUTCOME;

ANTIGENS, NEOPLASM; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; INJECTIONS, INTRAVENOUS; INTERFERON-ALPHA; MELANOMA; NEOPLASM PROTEINS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 54849403599     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Piérard-Franchimont C, Burg G, Grosshans E, et al. - Prévalence des cancers de la peau en région mosane et dans des pays européens de même latitude. Rev Med Liège, 1989, 44, 541-545.
2. Brochez L, Verhaeghe E, Bleyen L, et al. - Underregistration of melanoma in Belgium : an analysis. Melanoma Res, 1999, 9, 413-418.
3. Piérard-Franchimont C, Uhoda I, Piérard GE. - Cutaneous cancers in the Mosan region and Ardennes of Belgium. Dermatology, 1999, 198, 187-191.
4. Quatresooz P, Uhoda I, Fumal I, et al. - Revisiting the gender-linked melanoma burden. Dermatology, 2004, 209, 197-201.
5. Uhoda I, Quatresooz P, Fumal I, et al. - Updating trends in cutaneous cancers in south-east Belgium. Oncol Rep, 2004, 12, 111-114.
6. Quatresooz P, Piérard-Franchimont C, Piérard GE. - Space-time clustering and seasonality in diagnosing skin cancers in Wallonia (South East Belgium). Dermatology, 2008, 217, 48-51.
7. Naeyaert JM. - The melanoma burden in Belgium : premature morbidity and mortality make melanoma a considerable health problem. Melanoma Res, 1999, 9, 614-618.
8. Lehembre S, Carvalho P, Young P, et al. - Prise en charge des malades en fin de vie dans un service de dermatologie. Ann Dermatol Venereol, 2006, 133, 967-970.
9. Grange F. - Quoi de neuf en cancérologie cutanée ? Ann Dermatol Venereol, 2007, 134, 8 S53-8 S63.
10. Quatresooz P, Arrese JE, Piérard-Franchimont C, Piérard GE. - Immunohistochemical aid at risk stratification of melanocytic neoplasms. Int J Oncol, 2004, 24, 211-216.
11. Ciaessens N, Piérard GE, Piérard-Franchimont C, et al. - Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement. Melanoma Res, 2005, 15, 107-110.
12. Quatresooz P, Hustinx R, Piérard-Franchimont C, Piérard GE. - Le mélanome cutané dans une perspective liégeoise. Actualisation de son épidémiologie et avancées diagnostiques. Rev Med Liège, 2007, 62, S52-S55.
13. Quatresooz P, Piérard-Franchimont C, Piérard GE. - Highlighting the immunohistochemical profile of melanocytomas. Oncol Rep, 2008, 19, 1367-1372.
14. Quatresooz P, Piérard-Franchimont C, Rorive A, et al. - Molecular histology on the diagnostic cutting edge between malignant melanomas and melanocytomas. J Eur Acad Dermatol Venereol, sous presse.
15. Piérard GE, Scheen A. - Glossaire initiatique aux recherches cliniques. Rev Med Liège, 2006, 61, 190-194.
16. Karlsson PM, Fredrikson M. - Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002 : the increasing trend is broken. Int J Cancer, 2007, 121, 323-328.
17. Jemal A, Siegel R, Ward, E, et al. - Cancer statistics, 2007. CA Cancer J Clin, 2007, 57, 43-66.
18. Lipsker D, Engel F, Cribier B, et al. - Trends in epidemiology suggest three different types of melanoma. Arch Dermatol, 2007, 157, 338-343.
19. Clark NL, Shin DB, Troxel AB, et al. - Association between the anatomic distribution of melanoma and sex. J Am Acad Dermatol, 2007, 56, 768-773.
20. Verdaccia A, Francisci S, Brenner H, et al. - Recent cancer survival in Europe : a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol, 2007, 8, 784-796.
21. Berrino F, De Angelis R, Sant M, et al. - Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99 : results of the EUROCARE-4 study. Lancet Oncol, 2007, 8, 773-778.
22. Lasithiotakis KG, Leiter U, Eigentier T, et al. - Improvement of survival of patients with cutaneous melanoma in Germany, 1976-2001 : which factors contributed ? Cancer, 2007, 109, 1174-1182.
23. Piérard GE, Piérard-Franchimont C, Henry C, Lapière M. - The proliferative activity of cells of malignant melanomas. Am J Dermatopathol, 1984, 6, S317-S324.
24. Lipsker D. - Growth rate, early detection and prevention of melanoma. Melanoma epidemiology revisited and future challenges. Arch Dermatol, 2006, 142, 1638-1640.
25. Liu W, Dowling JP, Murray WK, et al. - Rate of growth in melanomas. Characteristics and associations of rapidly growing melanoma. Arch Dermatol, 2006, 142, 1551-1558.
26. Liu W, Kelly JW, Trivett M, et al. - Distinct clinical and pathological features are associated with BRAF mutation in primary melanoma. J Invest Dermatol, 2007, 127, 900-905.
27. Piérard-Franchimont C, Henry F, Heymans O, Piérard GE. - Vascular retardation in dormant growth-stunted malignant melanomas. Int J Mol Med, 1999, 4, 403-406.
28. Piérard GE, Piérard-Franchimont C. - Dépistage et diagnostic précoce du mélanome cutané. Rev Med Liège, 1995, 50, 525-529.
29. Baumert J, Plewig G, Volkenandt M, Schmid-Wendtner MH. - Factors associated with high tumour thickness in patients with melanoma. Br J Dermatol, 2007, 156, 938-944.
30. Fearfield LA, Larkin JMG, Rowe A, et al. - Expression of p16, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma. Br J Dermatol, 2007, 156, 440-447.
31. Gimotty PA, Elder DE, Fraker DL, et al. - Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol, 2007, 25, 1129-1134.
32. Gietema HA, Vuylsteke RJ, de Jonge IA, et al. - Sentinel lymph node investigation in melanoma : detailed analysis of the yield for step sectioning and immunohistochemistry. J Clin Pathol, 2004, 57, 618-620.
33. Spanknebel K, Coit DG, Bieligk SC, et al. - Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology : recommendations for standardizing pathologic analysis. Am J Surg Pathol, 2005, 29, 305-317.
34. Johnson TM, Sondak VK, Bichakjian CK, Sabel MS. - The role of sentinel lymph node biopsy for melanoma : evidence assessment. J Am Acad Dermatol, 2007, 54, 19-27.
35. Zogakis TG, Essner R, Wang HJ, et al. - Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes. Ann Surg Oncol, 2007, 14, 1604-1611.
36. Satzger I, Völker B, Ghazal MA, et al. - Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology, 2007, 50, 764-772.
37. Debarbieux S, Duru G, Dalle S, et al. - Sentinel lymph node biopsy in melanoma : a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol, 2007, 157, 58-67.
38. Van Akkooi AJC, de Wilt JHW, Verhoef C, et al. - Clinical relevance of melanoma micrometastases (< 0,1 mm) in sentinel nodes : are these nodes to be considered negative ? Ann Oncol, 2006, 17, 1578-1585.
39. Piérard-Franchimont C, Piérard GE. - Comment j'explore... un patient atteint de mélanome : actualisation d'un algorithme. Rev Med Liège, 2006, 61, 837-842.
40. Quatresooz P, Hustinx R, Piérard-Franchimont C, Piérard GE. - Le mélanome cutané dans une perspective liégeoise. Actualisation de son épidémiologie et avancées diagnostiques. Rev Med Liège, 2007, 62, S52-S55.
41. Saiag P, Bosquet L, Guillot B, et al. - Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French standards, options and recommendations guidelines. Summary report. Eur J Dermatol, 2007, 17, 325-331.
42. Eggermont AM, Suciu S, Santinami M, et al. - Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma : final results of EORTC 18991, a randomised phase III trial. Lancet, 2008, 372, 117-126.
43. Ralph SJ. - An update on malignant melanoma. Vaccine research. Insights into mechanisms for improving the design and potency of melanoma therapeutic vaccines. Am J Clin Dermatol, 2007, 8, 123-141.